Health
Jonathan Wall receives $1.79 million to develop new amyloidosis treatment – EurekAlert
The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science…
IMAGE: Dr. Jonathan Wall
view more
Credit: UTHSC
Memphis, Tenn. (March 16, 2021) – The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled “Developing a Theranostic Immunotherapy for Systemic Amyloidosis.”
Amyloidosis is a rare disease that occurs when abnormal protein aggregates (called amyloid)…
-
Noosa News12 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
Business23 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News22 hours agoMan shot in the leg during attempted break-in at Beenleigh, Queensland
-
General13 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle